Last10K.com

Healthcare Trust Of America Holdings, Lp (1495491) SEC Filing 10-Q Quarterly Report for the period ending Wednesday, June 30, 2021

Healthcare Trust Of America Holdings, Lp

CIK: 1495491

Exhibit 99.1
bestinclasslogoa17a.jpg
PRESS RELEASE
Financial Contact:
Robert A. Milligan
Chief Financial Officer
480.998.3478

HEALTHCARE TRUST OF AMERICA, INC. REPORTS SECOND QUARTER 2021 EARNINGS AND UPDATES 2021 GUIDANCE
Conference Call to be held on Tuesday, August 3, 2021 at 6:00 p.m. Eastern Time (3:00 p.m. Pacific Time)
Scottsdale, Arizona (August 3, 2021) - Healthcare Trust of America, Inc. (NYSE: HTA) (“HTA”) announced results for the three and six months ended June 30, 2021.
Second Quarter 2021 Highlights:
Reported net income attributable to common stockholders of $0.17 per diluted share.
Reported Funds From Operations (“FFO”), as defined by NAREIT, of $0.44 per diluted share, an increase of 10.0% compared to Q2 2020.
Reported Normalized FFO of $0.44 per diluted share, an increase of 4.8% compared to Q2 2020.
Reported Normalized FAD of $81.0 million, an increase of 4.5% compared to Q2 2020.
Reported Same-Property Cash Net Operating Income (“NOI”) growth of 2.1% compared to Q2 2020.

Year-to-date 2021:
Reported net income attributable to common stockholders of $60.0 million, or $0.27 per diluted share.
Reported FFO of $0.88 per diluted share, an increase of 7.3% compared to 2020.
Reported Normalized FFO of $0.88 per diluted share, an increase of 4.8% compared to 2020.
Reported Normalized FAD of $169.7 million, an increase of 9.6% compared to 2020.

Portfolio Performance
As of June 30, 2021, our portfolio had a leased rate of 89.3% by gross leasable area (“GLA”) and an occupancy rate of 87.9% by GLA.
During Q2 2021, HTA executed leases of 647 thousand square feet of GLA, including 150 thousand square feet of GLA in new leases and 497 thousand square feet of GLA in renewals. Re-leasing spreads were 2.1% and tenant retention for the Same-Property portfolio was 80% by GLA.
Year-to-date, HTA executed leases of approximately 1.4 million square feet of GLA, including 359 thousand square feet of GLA in new leases and 993 thousand square feet of GLA in renewals. Re-leasing spreads were 2.6% and tenant retention for the Same-Property portfolio was 73% by GLA.

Investment Activity
As of today, HTA has closed on or executed exclusive letters of intent on a total of approximately $373 million of investments on a year-to-date basis, including $304 million of medical office acquisitions that have closed or are under exclusive contract, subject to customary closing conditions, and $69 million in loan funding commitments to projects in the Texas Medical Center in Houston. This total includes $68.5 million of investments closed in the second quarter, including a $20 million acquisition of an MOB in Charleston, South Carolina and $48.5 million of loans associated with the previously announced Texas A&M Innovation Plaza in the Texas Medical Center in Houston that were funded within the quarter.
From a development perspective, HTA's existing projects remain on-track for delivery in 2021, while its pipeline of projects in pre-leasing have increased to over $375 million. In the second quarter, HTA completed its development projects in Miami, Florida and Bakersfield, California, which total approximately $51 million of investment with 136,000 square feet of GLA and are currently 82% leased.
HTA's development pipeline consists of five projects in the pre-leasing process, totaling over 850 thousand square feet of GLA. These projects are located in Houston, Orlando and Raleigh and are highlighted by HTA's previously announced strategic partnership with Medistar Corporation to co-develop the Texas A&M Innovation Plaza - Horizon Tower located in Houston, Texas, a 485,000 square foot medical office and life sciences tower with anticipated costs of $215 million expected to commence construction in 2022.
During the three months ended June 30, 2021, HTA closed on the previously announced disposition of a 13 property portfolio with locations in Tennessee and Virginia, with an aggregate gross sales price of $67.5 million. This transaction qualified as a 1031 exchange with net proceeds held in a restricted cash account at quarter end. This portfolio generated annual returns of 10% over its 13-year period and generated a gain of approximately $32.8 million.


The following information was filed by Healthcare Trust Of America Holdings, Lp on Tuesday, August 3, 2021 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Healthcare Trust Of America Holdings, Lp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Healthcare Trust Of America Holdings, Lp.

Continue

Assess how Healthcare Trust Of America Holdings, Lp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Healthcare Trust Of America Holdings, Lp's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Cover Page
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parenthetical)
Condensed Consolidated Statements Of Cash Flows
Condensed Consolidated Statements Of Changes In Partners' Capital
Condensed Consolidated Statements Of Changes In Partners' Capital (Parenthetical)
Condensed Consolidated Statements Of Comprehensive Income (Loss)
Condensed Consolidated Statements Of Equity
Condensed Consolidated Statements Of Equity (Parenthetical)
Condensed Consolidated Statements Of Operations
Commitments And Contingencies
Commitments And Contingencies (Details)
Debt
Debt (Tables)
Debt - Amortization Of Deferred Financing Costs (Details)
Debt - Narrative (Details)
Debt - Principal Maturity Schedule (Details)
Debt - Schedule Of Debt (Details)
Derivative Financial Instruments And Hedging Activities
Derivative Financial Instruments And Hedging Activities (Tables)
Derivative Financial Instruments And Hedging Activities - Derivative Instruments Fair Value Table (Details)
Dispositions And Impairment
Dispositions And Impairment (Details)
Fair Value Of Financial Instruments
Fair Value Of Financial Instruments (Tables)
Fair Value Of Financial Instruments - Assets And Liabilities Measured On Recurring Basis (Details)
Fair Value Of Financial Instruments - Assets Measured On Non-Recurring Basis (Details)
Intangible Assets And Liabilities
Intangible Assets And Liabilities (Tables)
Intangible Assets And Liabilities - Summary Of Intangible Amortization (Details)
Intangible Assets And Liabilities - Summary Of Intangible Assets And Liabilities (Details)
Investments In Real Estate
Investments In Real Estate (Tables)
Investments In Real Estate - Acquisitions (Details)
Investments In Real Estate - Purchase Price Allocation (Details)
Investments In Real Estate - Weighted Average Lives (Details)
Leases
Leases (Tables)
Leases - Lease Revenues And Maturity Of Future Minimum Rents (Details)
Leases - Maturity Of Lease Liabilities (Details)
Leases - Narrative (Details)
Organization And Description Of Business
Organization And Description Of Business (Details)
Per Share Data Of Hta
Per Share Data Of Hta (Details)
Per Share Data Of Hta (Tables)
Per Unit Data Of Htalp
Per Unit Data Of Htalp (Details)
Per Unit Data Of Htalp (Tables)
Receivables And Other Assets
Receivables And Other Assets (Tables)
Receivables And Other Assets - Amortization (Details)
Receivables And Other Assets - Schedule Of Receivables And Other Assets (Details)
Stockholders' Equity And Partners' Capital
Stockholders' Equity And Partners' Capital (Tables)
Stockholders' Equity And Partners' Capital - Narrative (Details)
Stockholders' Equity And Partners' Capital - Restricted Common Stock Activity (Details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)
Summary Of Significant Accounting Policies - Narrative (Details)
Supplemental Cash Flow Information
Supplemental Cash Flow Information (Details)
Supplemental Cash Flow Information (Tables)
CIK: 1495491
Form Type: 10-Q Quarterly Report
Accession Number: 0001360604-21-000053
Submitted to the SEC: Thu Aug 05 2021 4:20:10 PM EST
Accepted by the SEC: Thu Aug 05 2021
Period: Wednesday, June 30, 2021
Industry: Real Estate Investment Trusts

External Resources:

Bookmark the Permalink:
https://last10k.com/sec-filings/1495491/0001360604-21-000053.htm